We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

B&E Scientific

B&E Scientific designs, manufactures and markets products for clinical diagnostic applications. It offers hematology ... read more Featured Products: More products

Download Mobile App




Handheld Blood Gas Electrolyte Analyzer Advances Point-of-Care Testing (POCT)

By LabMedica International staff writers
Posted on 04 Jul 2023
Print article
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)
Image: The i-Check handheld blood gas electrolyte analyzer (Photo courtesy of B&E)

A vital factor for patients in emergency and critical care settings is their rapidly changing physiological state, which can deteriorate quickly and necessitate immediate diagnosis and clinical decisions for improving patient outcomes. Point-of-care testing (POCT) is a significant advancement in critical care settings, designed to provide decentralized, patient-centered healthcare. Quick access to blood measurements, especially blood gases, and electrolytes, can lead to better clinical outcomes. Now, a new handheld blood gas electrolyte analyzer designed to meet the urgency of clinical decision provides prompt POCT and improves patient outcomes while reducing therapeutic turnaround time (TTAT) and shortening door-to-clinical-decision time.

The newly-launched i-Check handheld blood gas electrolyte analyzer from B&E Biotechnology Co. Ltd. (Yantai, China) adopts microfluidic and electrochemical detection technology. Its single-use cartridge includes a plastic substrate, a multi-biosensor array, a calibrator pouch, a sample injection port, and a waste chamber. Notably, the multi-biosensor array is produced by silk-screen printing. The printing ink materials used comprise only carbon, silver, and insulation, without any noble metal, which significantly lowers the production cost compared to other manufacturers. Furthermore, special production technology enables its long-term stability to last 12 months under refrigeration. The i-Check handheld blood gas electrolyte analyzer requires only 95 μL of blood to measure pH, PCO2, PO2, K, Na, iCa, Hct, etc. in just one minute.

Among other benefits, the cartridge can be used immediately after removal from the refrigerator and does not need to be brought up to room temperature due to the efficient heating effect of the attached carbon heating film. It can rapidly increase the temperature of the electrode and flow path and maintain them at 37℃ when paired with an IR temperature sensor. Each cartridge has its own standard solution (calibrator), facilitating a one-point calibration, and eliminating the need for an additional reagent package. Calibration before sample injection is performed to prevent the impact of blood cell precipitation on Hct testing. Each cartridge also contains a unique RFID chip for quality control, effectively avoiding erroneous results from using expired cartridges. In a correlation experiment with a desktop blood gas analyzer, the i-Check excelled in test performance with correlation coefficients R2 all above 0.973 (n=76).

Related Links:
B&E Biotechnology Co. Ltd. 

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Herpes Simplex Virus ELISA
HSV 2 IgG – ELISA
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The advanced molecular test is designed to improve diagnosis of a genetic form of COPD (Photo courtesy of National Jewish Health)

Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD

Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.